These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1311629)

  • 1. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.
    Baghdiguian S; Verrier B; Gerard C; Fantini J
    Cancer Lett; 1992 Feb; 62(1):23-33. PubMed ID: 1311629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
    Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
    Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4.
    Fantini J; Rognoni JB; Roccabianca M; Pommier G; Marvaldi J
    J Biol Chem; 1989 Jun; 264(17):10282-6. PubMed ID: 2656707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
    Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
    J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells.
    Remacle-Bonnet M; Garrouste F; el Atiq F; Roccabianca M; Marvaldi J; Pommier G
    Int J Cancer; 1992 Dec; 52(6):910-7. PubMed ID: 1281142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6].
    Baghdiguian S; Pichon J; Marvaldi J; Fantini J
    Bull Cancer; 1991; 78(9):807-17. PubMed ID: 1751832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. Unique apical sorting of insulin-like growth factor binding protein-6 in differentiated human colon cancer cells.
    Remacle-Bonnet M; Garrouste F; el Atiq F; Marvaldi J; Pommier G
    J Clin Invest; 1995 Jul; 96(1):192-200. PubMed ID: 7542277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
    Garrouste FL; Remacle-Bonnet MM; Lehmann MM; Marvaldi JL; Pommier GJ
    Endocrinology; 1997 May; 138(5):2021-32. PubMed ID: 9112401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium.
    Fantini J; Verrier B; Robert C; Pic P; Pichon J; Mauchamp J; Marvaldi J
    Exp Cell Res; 1990 Jul; 189(1):109-17. PubMed ID: 2161345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of biochemical, electrophysiological and morphological events (including lysosomal disorder) during the course of suramin-induced differentiation of the human colon-cancer cell clone HT29-D4.
    Baghdiguian S; Verrier B; Marvaldi J; Fantini J
    Int J Cancer; 1991 Oct; 49(4):608-15. PubMed ID: 1917163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
    Minniti CP; Maggi M; Helman LJ
    Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
    Arteaga CL; Osborne CK
    Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cells.
    Baghdiguian S; Verrier B; Marvaldi J; Fantini J
    J Cell Physiol; 1992 Jan; 150(1):168-74. PubMed ID: 1730780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
    Fantini J; Rognoni JB; Verrier B; Lehmann M; Roccabianca M; Mauchamp J; Marvaldi J
    Eur J Cell Biol; 1990 Feb; 51(1):110-9. PubMed ID: 2328732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A suramin derivative induces enterocyte-like differentiation of human colon cancer cells without lysosomal storage disorder.
    Baghdiguian S; Nickel P; Marvaldi J; Fantini J
    Anticancer Drugs; 1990 Oct; 1(1):59-66. PubMed ID: 2131040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells.
    Pollak M; Richard M
    J Natl Cancer Inst; 1990 Aug; 82(16):1349-52. PubMed ID: 2166171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.
    Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL
    Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells.
    Tsutsumi K; Kitagawa N; Niwa M; Himeno A; Taniyama K; Shibata S
    J Neurosurg; 1994 Mar; 80(3):502-9. PubMed ID: 8113863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line.
    Remacle-Bonnet MM; Culouscou JM; Garrouste FL; Rabenandrasana C; Marvaldi JL; Pommier GJ
    J Clin Endocrinol Metab; 1992 Aug; 75(2):609-16. PubMed ID: 1322432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface distribution of the EGF receptor during differentiation of the human colon carcinoma cell line HT29-D4.
    Lehmann M; Remacle-Bonnet M; Garrouste F; Luis J; Rabenandrasana C; Marvaldi J; Pommier G
    J Recept Res; 1994 Jul; 14(5):319-33. PubMed ID: 7815389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.